Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biocartis appoints new CEO

This article was originally published in Clinica

Executive Summary

Swiss molecular diagnostics company Biocartis has appointed Nayan Gregory Parekh CEO. He replaces current head and company co-founder Rudi Pauwels, who will become executive chairman and focus on the firm's scientific and technology strategy. Dr Parekh has been an executive director on Biocartis's board since April. His experience is mainly in financing and investment; Dr Parekh was most recently at New Rhein Healthcare, an investment firm which he co-founded. Prior to this, he spent six years as head of corporate development at Novartis, where he led the company's investments across different product areas and in various emerging markets.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT098240

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel